We found that cZNF292 silencing can significantly downregulate the activity of the above transcription factors and the expression of β-catenin, suggesting that signal transduction in the STAT3/5/β-catenin pathway is also a potential mechanism through which cZNF292 exerts its regulatory role in glioma cells. This evidence concerns the gene STAT3 and central nervous system cancer.